Citations

Showing 10 of 108081 citations.

Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
Debes, José D. , Chan, Aaron J., Balderramo, Domingo , Kikuchi, Luciana , Ballerga, Esteban González , Prieto, Jhon , Tapias, Mónica, Idrovo, Víctor, Davalos, Milagros B., Cairo, Fernando , Barreyro, Fernando Javier , Paredes, Sebastián , Hernández, Nelia , Avendaño, Karla, Ferrer, Javier Díaz , Yang, Ju Dong , Carrera, Enrique , Garcia, Jairo A., Mattos, Ângelo Zambam de , Hirsch, Bruno Salomão , Gonçalves, Pablo T., Carrilho, Flair José , Roberts, Lewis R. , Hernández, Nelia , Yang, Ju Dong , Roberts, Lewis R

Mayo Clinic

Liver International | June 22, 2017 | Volume: 38 | Issue: 1 | Pages: 136-143

10.1111/liv.13502 | PMID 28640517 Get It

AbstractBackground & AimsHepatocellular carcinoma (HCC) is the second leading cause of cancer‐related death worldwide. Most studies addressing the epidemiology of HCC originate from developed countries. This study reports the preliminary findings of a multinational approach to characterize HCC in South America.MethodsWe evaluated 1336 HCC patients seen at 14 centres in six South American countries using a retrospective study design with participating centres completing a template chart of patient characteristics. The diagnosis of HCC was made radiographically or histologically for all cases according to institutional standards. Methodology of surveillance for each centre was following AASLD or EASL recommendations.ResultsSixty‐eight percent of individuals were male with a median age of 64 years at time of diagnosis. The most common risk factor for HCC was hepatitis C infection (HCV, 48%), followed by alcoholic cirrhosis (22%), Hepatitis B infection (HBV, 14%) and NAFLD (9%). We found that among individuals with HBV‐related HCC, 38% were diagnosed before age 50. The most commonly provided therapy was transarterial chemoembolization (35% of HCCs) with few individuals being considered for liver transplant (<20%). Only 47% of HCCs were diagnosed during surveillance, and there was no difference in age of diagnosis between those diagnosed incidentally vs by surveillance. Nonetheless, being diagnosed during surveillance was associated with improved overall survival (P = .01).ConclusionsOur study represents the largest cohort to date reporting characteristics and outcomes of HCC across South America. We found an important number of HCCs diagnosed outside of surveillance programmes, with associated increased mortality in those patients.
Estimation of signal and noise for a whole-body research photon-counting CT system
Li, Zhoubo , Yu, Zhicong , Kappler, S. , Leng, Shuai , McCollough, Cynthia H. , McCollough, Cynthia H , Leng, Shuai , Kappler, Steffen

Mayo Clinic

Journal of Medical Imaging | June 22, 2017 | Volume: 4 | Issue: 2 | Pages: 023505

10.1117/1.jmi.4.2.023505 | PMID 28653013 Get It

Healthcare Provider Education to Support Integration of Pharmacogenomics in Practice: The Emerge Network Experience
Vitek, Carolyn R. Rohrer , Abul‐Husn, Noura S. , Connolly, John J. , Hartzler, Andrea L. , Kitchner, Terrie, Peterson, Josh F. , Rasmussen, Luke V. , Smith, Maureen E. , Stallings, Sarah , Wolf, Wendy A. , Prows, Cynthia A. , Rohrer Vitek, Carolyn R, Williams, Marc S , Rasmussen, Luke V , Connolly, John J , Peterson, Josh F

Mayo Clinic

Pharmacogenomics | June 22, 2017 | Volume: 18 | Issue: 10 | Pages: 1013-1025

10.2217/pgs-2017-0038 | PMID 28639489 Get It

Intravenous Alteplase for Acute Stroke and Pulmonary Embolism in a Patient With Recent Abdominoplasty
Christiansen, Michael E., Kumar, Gyanendra , Mahabir, Raman C. , Helmers, Richard A. , O’Carroll, Cumara B. , Bendok, Bernard R.

Mayo Clinic

The Neurologist | June 22, 2017 | Volume: 22 | Issue: 4 | Pages: 150-152

10.1097/nrl.0000000000000139 | PMID 28644260 Get It

Introduction: Major surgery in the past 14 days is a relative contraindication to treatment of acute stroke with intravenous (IV) alteplase. The 2016 American Heart Association/American Stroke Association scientific statement discussing inclusion and exclusion criteria for alteplase in acute stroke allows for provider judgment citing a lack of evidence to support surgery as an absolute contraindication. Case Report: A 59-year-old woman presented with acute left hemiparesis, dysarthria, and acute respiratory failure. National Institutes of Health Stroke Scale was 17. Two days prior she underwent abdominoplasty and liposuction. Computed tomography angiogram of the head demonstrated acute occlusion of right M2, and computed tomography angiogram of the chest was positive for bilateral pulmonary emboli. After urgent consultation with the plastic surgery and neurosurgery teams, the patient was treated with IV alteplase followed by cerebral mechanical thrombectomy. This was complicated by surgical-site hemorrhage in the abdomen requiring operative intervention. Abdominal hemorrhage was controlled and the patient showed remarkable neurological recovery, later being discharged with no residual neurological deficits. Conclusions: Interdisciplinary collaboration can successfully inform the decision to treat acute ischemic stroke with IV alteplase in the setting of recent major surgery.
Spectrum of Autonomic Nervous System Impairment in Sjögren Syndrome
Goodman, Brent P., Crepeau, Amy Z. , Dhawan, Priya S., Khoury, Julie, Harris, Lucinda A.

Mayo Clinic

The Neurologist | June 22, 2017 | Volume: 22 | Issue: 4 | Pages: 127-130

10.1097/nrl.0000000000000134 | PMID 28644253 Get It

Objective: To describe the spectrum of autonomic dysfunction in a uniformly evaluated cohort of patients with Sjögren syndrome. Methods: A series of 13 patients underwent a comprehensive evaluation for suspected autonomic impairment, including a neurological examination, autonomic testing, and laboratory studies. A diagnosis of Sjögren syndrome was established as the cause of autonomic dysfunction in all. Clinical features, findings on autonomic testing, and laboratory results are described. Results: All patients in this series reported postural lightheadedness and syncope or near-syncope. Autonomic testing confirmed the presence of orthostatic hypotension on tilt-table testing in 5 patients and an excessive postural tachycardia and/or hypertensive response in 8 patients. Only 2 of the patients with orthostatic hypotension had a significant sensory neuropathy. Symptoms suggestive of gastrointestinal and genitourinary impairment were seen in nearly all patients, with abnormal motility testing (most frequently esophageal dysmotility) in 5 of 6 patients who underwent formal testing. Patients in this series treated with immune-modulating therapy experienced significant improvement. Conclusions: A diagnosis of Sjögren syndrome should be aggressively pursued in patients with signs and symptoms suggestive of autonomic nervous system impairment. Although the spectrum of adrenergic failure is variable, ranging from orthostatic hypotension to an excessive postural tachycardia, most patients do have symptoms of more generalized autonomic failure. Patients who were treated with immune-modulating therapy did improve.
Antiphospholipid Syndrome With a Distinctive Constellation of Neurological Manifestations
Nokes, Brandon , Dumitrașcu, Oana , Shamoun, Fadi , O’Carroll, Cumara B. , Nokes, Brandon T

Mayo Clinic

The Neurologist | June 22, 2017 | Volume: 22 | Issue: 4 | Pages: 147-149

10.1097/nrl.0000000000000133 | PMID 28644259 Get It

Antiphospholipid syndrome (APS) encompasses a hypercoagulable state with a markedly increased risk for cerebrovascular complications. In addition to the classic stroke features of APS, however, there are numerous recently described “non-criteria” neurological conditions such as headaches, seizures, and cognitive impairment. We present a case of APS with uncommon neurological manifestations.
Is Intravenous Thrombolysis Safe and Effective in Central Retinal Artery Occlusion? A Critically Appraised Topic
Dumitrascu, Oana M. , Shen, Joanne F , Kurli, Madhavi, Aguilar, Maria I. , Wingerchuk, Dean M. , O’Carroll, Cumara B. , Marks, Lisa , Demaerschalk, Bart M.

Mayo Clinic

The Neurologist | June 22, 2017 | Volume: 22 | Issue: 4 | Pages: 153-156

10.1097/nrl.0000000000000129 | PMID 28644261 Get It

Background: Central retinal artery occlusion (CRAO) is a neurological and ophthalmologic emergency associated with poor visual recovery. There is a dilemma regarding the appropriate treatment, as formal guidelines are lacking. Despite being considered an ocular equivalent of cerebral infarction, the time window of intravenous (IV) thrombolysis administration for maximum efficacy and safety in CRAO remains uncertain. Objective: To critically assess the current evidence regarding the safety and effectiveness of IV thrombolysis in the treatment of patients with CRAO. Methods: The objective was addressed through the development of a critically appraised topic that included a clinical scenario, structured question, literature search strategy, critical appraisal, assessment of results, evidence summary, commentary, and bottom-line conclusions. Participants included consultant and resident neurologists, a medical librarian, and content experts in the fields of vascular neurology and ophthalmology. Results: A recent patient-level meta-analysis was selected for critical appraisal. The study compared the visual recovery rates after IV thrombolysis in CRAO against the natural history of this illness and conservative therapies (ocular massage, anterior chamber paracentesis, and/or hemodilution). Time to thrombolytic therapy administration had a significant impact on visual recovery in CRAO (P<0.001). IV thrombolysis within the first 4.5 hours after symptom onset resulted in recovery of vision in 50.0% of the patients [95% confidence interval (CI), 32.4%-67.6%]. The rate of visual recovery was nearly 3 times higher than in the natural history cohort [odds ratio, 4.7 (95% CI, 2.3-9.6); P<0.001], with a 32.3% absolute risk reduction and a number needed to treat of 4.0 (95% CI, 2.6-6.6). There was no significant difference in the recovery rate after thrombolysis compared with the natural history cohort for those patients treated after 4.5 hours. No major hemorrhages occurred after alteplase administration in this meta-analysis. Conclusions: IV thrombolysis in CRAO seems to be safe and effective within the first 4.5 hours of symptom onset. A clinical decision based on this meta-analysis alone cannot be made due to several limitations. A randomized controlled clinical trial of early IV alteplase administration in CRAO is necessary to provide evidence-based therapeutic guidance.
Early Infections and the Risk of Irritable Bowel Syndrome
Krajicek, Edward, Almazar, Ann E., Larson, Joseph J. , Atkinson, Elizabeth J. , Saito, Yuri A. , Talley, Nicholas J.

Mayo Clinic

Journal of Clinical Gastroenterology | June 22, 2017 | Volume: 52 | Issue: 10 | Pages: 896-901

10.1097/mcg.0000000000000869 | PMID 28644312 Get It

Goals: The goal of this study is to evaluate the association between early life infections and subsequent adult onset irritable bowel syndrome (IBS). Background: Infections during adulthood are a known risk factor for adult-onset IBS. This investigation examined the role of childhood infections and infection risk factors in the development of IBS symptoms. Study: In total, 1010 subjects (509 outpatients with IBS, 501 matched controls) were mailed questionnaires regarding early-life infections during infancy (0 to 12 mo), toddler years (1 to 3 y), and child years (4 to 18 y). Comparisons between cases and controls were performed using logistic regression adjusting for age, gender, and somatization score. Results: Around 648 (64.2%) subjects responded. The median age was 51.3 years (range, 18.0 to 70.7 y) and 535 (83%) were female. Childhood (below 18 y) infections were common in cases and controls (98% vs. 98%; P=0.465), with no differences between cases and controls during infant, toddler, and child-age periods. For gastrointestinal infections experienced below 18 years, no differences were observed by infection type (bacterial, viral, or parasitic) or age group. Cases were more likely to report bronchitis by age 18 [43% vs. 25%; P=0.003; odds ratio, 1.73 (1.20-2.51)], but not other common infections. Regular antibiotic exposure was greater amongst cases (43%) than controls (30%) [P=0.09; odds ratio, 1.37 (0.96-1.96)]. The association between bronchitis and IBS case status remained significant after adjusting for antibiotic use (P=0.01). Conclusions: Greater early childhood gastrointestinal infections rates were not observed in adult individuals with IBS compared with adult controls. The study does not support a statistically significant link between early life infections and IBS aside from bronchitis.
Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis
Jaruvongvanich, Veeravich , Ahuja, Wasin , Wirunsawanya, Kamonkiat , Wijarnpreecha, Karn , Ungprasert, Patompong , Wijarnpreecha, Karn

Mayo Clinic

European Journal of Gastroenterology & Hepatology | June 22, 2017 | Volume: 29 | Issue: 9 | Pages: 1031-1035

10.1097/meg.0000000000000931 | PMID 28639970 Get It

Background Hyperuricemia is a significant risk factor for nonalcoholic fatty liver disease (NAFLD). It may also have an impact on the histologic severity of NAFLD. However, data on this association are limited. We conducted this meta-analysis to investigate the relationship of serum uric acid with liver histologic severity as determined by NAFLD activity score (NAS) in patients with NAFLD. Patients and methods MEDLINE and EMBASE databases were searched through August 2016 for studies that investigated the association between hyperuricemia and NAS among patients with biopsy-proven NAFLD. Pooled odds ratio and 95% confidence interval were calculated using a random-effects model (generic inverse variance method). The between-study heterogeneity of effect size was quantified using the Q statistic and I 2. Results Five observational studies with 777 NAFLD patients were identified. Patients with NAFLD who had hyperuricemia had a high NAS (defined as score of ≥5) significantly more often than did those without hyperuricemia with a pooled odds ratio of 2.17 (95% confidence interval: 1.51–3.12). The statistical heterogeneity was low, with I 2 of 16% (P heterogeneity=0.31). Conclusion In patients with NAFLD, hyperuricemia is associated with a higher degree of histological liver damage. Further studies are required to establish the role of uric acid-lowering therapy among these patients.
Cutaneous fungal infection in an immunocompromised host
Sotello, David , Cappel, Mark A. , Huff, Tamara, Meza, Diana, Álvarez, Salvador, Cappel, Mark, Libertin, Claudia R. , Sotello Aviles, David A

Mayo Clinic

JMM Case Reports | June 22, 2017 | Volume: 4 | Issue: 6 | Pages: No page available

10.1099/jmmcr.0.005101 | PMID 29026628 Get It